The 47 references in paper O. LYASHENKO A., K. GUREVICH Ya., A. KORNEEV M., О. ЛЯШЕНКО А., К. ГУРЕВИЧ Я., А. КОРНЕЕВ М. (2011) “КЛИНИЧЕСКИЕ, ЛАБОРАТОРНЫЕ И ИНСТРУМЕНТАЛЬНЫЕ ХАРАКТЕРИСТИКИ, АССОЦИИРОВАННЫЕ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ У БОЛЬНЫХ, НАХОДЯЩИХСЯ НА ПРОГРАММНОМ ГЕМОДИАЛИЗЕ // CLINICAL, LABORATORY AND ISTUMENTAL PARAMETERS ASSOCIATED WITH ARTERIAL PRESSURE AT PATIENTS’ ON PROGRAMMED HEMODIALYSIS” / spz:neicon:nefr:y:2011:i:2:p:49-56

1
Cohen EP. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dialys and Transplant
(check this in PDF content)
2
00; 29: 535-542 2. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient’s survival. Kidney Int 2000; 58 (5): P 2147-2154
(check this in PDF content)
3
Horl MP, Horl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227-244
(check this in PDF content)
4
Rocco MV, Yan G, Heyka RJ, Benz R et al.; HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol 2001; 21: 280–288
(check this in PDF content)
5
Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277
(check this in PDF content)
6
Pеrez-Garcia R, Martin-Malo A, Fort J, Cuevas X et al. Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER—a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009; 24 (2): 578-588
(check this in PDF content)
7
Бикбов БТ, Томилина НА. Состояние заместительной почечной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2007 гг. (Аналитический отчёт по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11 (3): 144-233
(check this in PDF content)
8
Paoletti E, Specchia C, Di Maio G et al. The worsening of the left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10year survey. Nephrol Dial Transplant 2004; 19: 1829-1834
(check this in PDF content)
9
Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13 (6): 125-131
(check this in PDF content)
10
Добронравов ВА, Боровская ЕА, Владимирова ЮФ, Смирнов АВ. Динамика артериального давления и его суточного профиля у пациентов на стандартном программном гемодиализе: данные двухсуточного мониторирования. Нефрология 2009; 13 (2): 42-49
(check this in PDF content)
11
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Jf Hypertens 1999; 17: 151-185
(check this in PDF content)
12
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618
(check this in PDF content)
13
DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871
(check this in PDF content)
14
Levy D, Savage DD et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960
(check this in PDF content)
15
Daugirdas JT. Simplified equations for monitoring KT/ V, PCRn, eKT/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295304.
(check this in PDF content)
16
European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 1999; 14 [Suppl 5]: 50p.
(check this in PDF content)
17
Leypoldt JK, Cheung AK, Delmez JA et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 2002; 61: 266-275
(check this in PDF content)
18
Luik AJ, van Kuijk WHM, Spek J et al. Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis
(check this in PDF content)
19
7; 30: 466-474 19. Ventura JE, Sposito M. Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant 1997; 12: 485-491
(check this in PDF content)
20
Wabel P, Moissl U, Chamney PC et al. Towards improved cardiovascular management: the necessity of comorbining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2957-2964
(check this in PDF content)
21
Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32 (5): 720-724
(check this in PDF content)
22
Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control Nephrol Dial Transplant 2006; 21 (12): 3506-3511
(check this in PDF content)
23
Agarwal R, Alborzi P, Satyan S et al. Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP). Hypertension 2009; 53: 500
(check this in PDF content)
24
Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечно-сосудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249
(check this in PDF content)
25
Ibrahim S, Taweel A. Influence of plasma volume status on blood pressure in patients on maintenance hemodialysis. Dialysis and Transplant 2007; 36 (1): 13-24
(check this in PDF content)
26
Волгина ГВ. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности (обзор литературы). Нефрология и диализ 2000; 2 (1-2): 25-32
(check this in PDF content)
27
Волгина ГВ, Перепеченых ЮВ, Бибков БТ и соавт. Факторы риска кардиоваскулярных заболеваний у больных с хронической почечной недостаточностью. Нефрология и диализ 2000; 2 (4): 252-258
(check this in PDF content)
28
Basile C, Lomonte C., Vernaglione L. et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 282-287
(check this in PDF content)
29
London GM, Guerin AP, Marchais SJ. Hemodynamic overload in the end-stage renal disease patients. Semin Dial 1999; 12: 77-83
(check this in PDF content)
30
Kooman JP, Van Der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 2004; 22: 55-59
(check this in PDF content)
31
Santos SF, Peixoto AJ. Hypertension in dialysis. Curr Opin Nephrol Hypertens 2005; 14: 111-118
(check this in PDF content)
32
Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10: 241-248
(check this in PDF content)
33
Tomson ChRV, Shresha SM. The pivotal role of sodium balance in control of blood pressure in dialysis patients. Hemodialysis International 2007; 11 [Suppl 2]: S21 – S26
(check this in PDF content)
34
Kooman JP, Van Der Sande FM, Leunissen KM. Sodium, blood pressure and cardiovascular pathology: is it all volaemia? Nephrol Dial Transplant 2004; 19: 1049-1049
(check this in PDF content)
35
Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66: 2454-2466
(check this in PDF content)
36
He FJ, Markandu ND, Sagnella GA et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45: 98-102
(check this in PDF content)
37
Ермоленко ВМ. Хроническая почечная недостаточность. В: Тареева ИЕ, ред. Нефрология. Руководство для врачей. Медицина, М., 2000; 596 – 644
(check this in PDF content)
38
Block GA, Hulbert-Shearon TE, Levin NW. et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617
(check this in PDF content)
39
Huang CX, Plantinga LC, Fink NE et al. Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study. Adv Chronic Kidney Dis 2008; 15 (3): 321331.
(check this in PDF content)
40
Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126
(check this in PDF content)
41
Triperi G, Mallamaci F, Zoccali C. Inflammantion markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16 [Suppl 1]: 83-88
(check this in PDF content)
42
Wanner C, Zimmermann J, Schwelder S. et al. Inflammantion and cardiovascular risk in dialysis patients. Kidney Int 2002; S80: 99-102
(check this in PDF content)
43
Honda H, Qureshi A, Heimburger O. et al. Serum albumin, C-reative protein , interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148
(check this in PDF content)
44
London GM. Pathophysisology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 2001; 16 (2): 3-6
(check this in PDF content)
45
Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037
(check this in PDF content)
46
U.S. Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diadetes and Digestive and Kidney Diseases, Bethesda, MD, 2003: 560
(check this in PDF content)
47
Harrison DG. Cellular and molecular mechanisms of endothelial dysfunction? J Clin Invest 1997; 100: 2153-2157 Ïîñòóïèëà â ðåäàêöèþ 24.01.2011 ã. Ïðèíÿòà â ïå÷àòü 09.02.2011 ã.
(check this in PDF content)